Murty Pharmaceuticals, Inc.("MPI") is a pharmaceutical research and development firm that specializes in novel formulations of new and existing chemical entities conducted in strict conformance with applicable cGMPs. For solid oral dosage forms, MPI can develop robust manufacturing processes for exhibit and commercial batches, and can manufacture clinical supplies to meet any client requirements. In addition, MPI provides regulatory support for submissions of NDAs, ANDAs, INDs, and CMCs from the onset, thereby reducing the need for redundant studies and reducing total costs of development.